Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2016

Open Access 01-12-2016 | Research article

Activities of daily living questionnaire from patients’ perspectives in Parkinson’s disease: a cross-sectional study

Authors: Su-Yun Lee, Sung Kwan Kim, Sang-Myung Cheon, Jung-Wook Seo, Min Ah Kim, Jae Woo Kim

Published in: BMC Neurology | Issue 1/2016

Login to get access

Abstract

Background

The aim of this study was to develop an assessment tool for activities of daily living (ADL) from the perspective of patients with Parkinson’s disease (PD) and examine the validity and reliability of the assessment.

Methods

A preliminary 45-item questionnaire was developed through intensive interviews with 54 patients with PD and administered to another group of 248 patients with PD. Based on clinical and statistical analyses, 20 ADL-items were selected. The final 20-item questionnaire was examined in the other group of 59 patients with PD.

Results

The new ADL questionnaire showed high internal consistency (Cronbach’s α, 0.962–0.966) and acceptable test-retest reliability (0.632–0.984). Concurrent validity was shown as a significant positive correlation between the new ADL questionnaire and other ADL or clinical instruments. The Hoehn and Yahr stage showed the highest degree of correlation with the new ADL questionnaire, followed by the other ADL scales (Schwab and England ADL and the ADL subscore of the Unified Parkinson’s Disease Rating Scale). Additionally, a regression analysis was conducted with the disease-specific quality of life questionnaire, and the new ADL questionnaire was the most powerful predictor of quality of life among the clinical instruments.

Conclusions

The new ADL questionnaire is a valid tool for assessing ADL from the perspectives of patients with PD.
Appendix
Available only for authorised users
Literature
1.
Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223–36. discussion 222.CrossRefPubMed
2.
Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–76.CrossRefPubMed
3.
Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000;15(6):1112–8.CrossRefPubMed
4.
Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, et al. The evolution of disability in Parkinson disease. Mov Disord. 2008;23(6):790–6.CrossRefPubMed
5.
Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58(10):1611–5.CrossRefPubMed
6.
Hobson JP, Edwards NI, Meara RJ. The Parkinson's Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson's disease. Clin Rehabil. 2001;15(3):241–6.CrossRefPubMed
7.
Keus S, Nieuwboer A, Bloem B, Borm G, Munneke M. Clinimetric analyses of the modified Parkinson activity scale. Parkinsonism Relat Disord. 2009;15(4):263–9.CrossRefPubMed
8.
Hariz G, Forsgren L. Activities of daily living and quality of life in persons with newly diagnosed Parkinson’s disease according to subtype of disease, and in comparison to healthy controls. Acta Neurol Scand. 2011;123(1):20–7.CrossRefPubMed
9.
Morley D, Selai C, Thompson A. The self-report Barthel Index: preliminary validation in people with Parkinson’s disease. Eur J Neurol. 2012;19(6):927–9.CrossRefPubMed
10.
Ramaker C, Marinus J, Stiggelbout AM, van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord. 2002;17(5):867–76.CrossRefPubMed
11.
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18(7):738–50.CrossRef
12.
Schrag A, Spottke A, Quinn NP, Dodel R. Comparative responsiveness of Parkinson's disease scales to change over time. Mov Disord. 2009;24(6):813–8.CrossRefPubMed
13.
Harrison MB, Wylie SA, Frysinger RC, Patrie JT, Huss DS, Currie LJ, et al. UPDRS activity of daily living score as a marker of Parkinson's disease progression. Mov Disord. 2009;24(2):224–30.CrossRefPubMedPubMedCentral
14.
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez‐Martin P, et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.CrossRefPubMed
15.
Keus SH, Bloem BR, Hendriks EJ, Bredero‐Cohen AB, Munneke M. Evidence‐based analysis of physical therapy in Parkinson's disease with recommendations for practice and research. Mov Disord. 2007;22(4):451–60.CrossRefPubMed
16.
Brusse KJ, Zimdars S, Zalewski KR, Steffen TM. Testing functional performance in people with Parkinson disease. Phys Ther. 2005;85(2):134–41.PubMed
17.
Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56(1):33–9.CrossRefPubMed
18.
Kang Y, Na DL, Hahn S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15(2):300–8.
19.
Kim S, Won J, Cho K. The validity and reliability of Korean version of Lawton IADL Index. J Korean Geriatr Soc. 2005;9(1):23–9.
20.
Nijkrake MJ, Keus SH, Quist-Anholts GW, Overeem S, De Roode MH, Lindeboom R, et al. Evaluation of a Patient-Specific Index as an outcome measure for physiotherapy in Parkinson's disease. Eur J Phys Rehabil Med. 2009;45(4):507–12.PubMed
21.
Group TCM, Martínez-Martin P, Gil-Nagel A, Gracia LM, Gómez JB, Martínez-Sarriés F, et al. Intermediate scale for assessment of Parkinson's disease. Characteristics and structure. Parkinsonism Relat Disord. 1995;1(2):97–102.CrossRef
22.
Katz S. Assessing self‐maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983;31(12):721–7.CrossRefPubMed
23.
Jung HY, Park BK, Shin HS, Kang YK, Pyun SB, Paik NJ, et al. Development of the Korean version of Modified Barthel Index (K-MBI): multi-center study for subjects with stroke. J Korean Acad Rehabil Med. 2007;31(3):283–97.
24.
Kim SY, Won CW, Rho YG, Yoon JL. The validity and reliability of Korean version of Karz ADL index. J Korean Geriatr Soc. 2004;8(2):62–8.
25.
Sikkes SA, de Lange-de Klerk ES, Pijnenburg YA, Scheltens P, Uitdehaag BM. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry. 2009;80(1):7–12.CrossRefPubMed
26.
Hahn H, Yum T, Shin Y, Kim K, Yoon D, Chung K. A standardization study of Beck Depression Inventory in Korea. J Korean Neuropsychiatr Assoc. 1986;25(3):487–500.
27.
Siddiqui M, Rast S, Lynn M, Auchus A, Pfeiffer R. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord. 2002;8(4):277–84.CrossRefPubMed
28.
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3.CrossRefPubMed
29.
de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 1996;61(1):70–4.CrossRefPubMedPubMedCentral
30.
Hinnell C, Hurt CS, Landau S, Brown RG, Samuel M. Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease? Mov Disord. 2012;27(2):236–41.CrossRefPubMed
Metadata
Title
Activities of daily living questionnaire from patients’ perspectives in Parkinson’s disease: a cross-sectional study
Authors
Su-Yun Lee
Sung Kwan Kim
Sang-Myung Cheon
Jung-Wook Seo
Min Ah Kim
Jae Woo Kim
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2016
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-016-0600-9

Other articles of this Issue 1/2016

BMC Neurology 1/2016 Go to the issue

Case report

Diagnosis and follow-up of posterior inferior cerebellar artery dissection complicated with ischemic stroke assisted by T1-VISTA: a report of two cases

Research article

Guidelines for dementia or Parkinson’s disease with depression or anxiety: a systematic review

Case report

A microdeletion at Xq22.2 implicates a glycine receptor GLRA4 involved in intellectual disability, behavioral problems and craniofacial anomalies

Research article

Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study

Research article

Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM

Research article

Assessment of primary rehabilitation needs in neurological rehabilitation: translation, adaptation and face validity of the Danish version of Rehabilitation Complexity Scale-Extended